Contents

Current Drug Targets, Volume 2 - Number 3

Preface

, 2(3): i

Francis J. Castellino


DOI: 10.2174/1389450013348362




NMDA Receptor Pharmacology: Perspectives from Molecular Biology

, 2(3): 215 - 231

David R. Lynch and Rodney P. Guttmann


DOI: 10.2174/1389450013348434




Subunit Characterization of NMDA Receptors

, 2(3): 233 - 239

F. Anne Stephenson


DOI: 10.2174/1389450013348461




Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies

, 2(3): 241 - 271

Gene C. Palmer


DOI: 10.2174/1389450013348335




NMDA Receptors and Learning and Memory Processes

, 2(3): 273 - 283

C. Castellano, V. Cestari and A. Ciamei


DOI: 10.2174/1389450013348515




Ifenprodil, a Novel NMDA Receptor Antagonist : Site and Mechanism of Action

, 2(3): 285 - 298

Keith Williams


DOI: 10.2174/1389450013348489




Convergence of PKC-Dependent Kinase Signal Cascades on NMDA Receptors

, 2(3): 299 - 312

J. F. Macdonald, S. A. Kotecha, W. Y. Lu and M. F. Jackson


DOI: 10.2174/1389450013348452




Structure-Function Relationships of the NMDA Receptor Antagonist Conantokin Peptides

, 2(3): 313 - 322

Mary Prorok and Francis J. Castellino


DOI: 10.2174/1389450013348542




Activators and Inhibitors of the Ion Channel of the NMDA Receptor

, 2(3): 323 - 329

Rebecca C. Klein and Francis J. Castellino


DOI: 10.2174/1389450013348290




The Use of Antibody Engineering to Create Novel Drugs that Target N-methyl-D-Aspartate Receptors

, 2(3): 331 - 345

Joseph R. Moskal, Hirotaka Yamamoto and Patricia A. Colley


DOI: 10.2174/1389450013348399




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science